THE EFFECTIVENESS OF BIOFEEDBACK IN THE TREATMENT OF DIFFICULT-TO-CONTROL ARTERIAL HYPERTENSION
Abstract
Review is devoted to difficult-to-control arterial hypertension and possibilities of biofeedback as additional method to standard antihypertensive therapy. Reasons and current approaches to therapy of difficult-to-control arterial hypertension are discussed. Particularities of biofeedback therapy and variants of the technical implementation of the different loops are described. Recent publications that contain data of the effectiveness of biofeedback among hypertensive patients are given. Relevance of this problem among patients with difficult-to-control arterial hypertension is proved.
Downloads
References
Unifikovanij klinichnij protokol pervinnoї, ekstrennoї ta vtorinnoї (specializovannoї) dopomogi «Arterial'na gipertenzijaǧ». – Praktichnij likar. – 2013. – № 2. – s.43–51.
Sung Sug (Sarah) Yoon. Hypertension Prevalence and Control Among Adults / Sung Sug (Sarah) Yoon, Cheryl D. Fryar, Margaret D. Carroll. // United States-NCHS Data Brief. – 2015. – № 220.
Kovalenko V. N. Rukovodstvo po kardiologii / Kovalenko V. N. – Kiiv: Morion, 2008. – 1404 s.
Amosova E. N. Klinicheskaja kardiologija / Amosova E. N. – Kiiv: Zdorov'e, 1998. – 704 s.
Systolic and diastolic short-term blood pressure variability and its determinants among patientss with controlled and uncontrolled hypertension: A retrospective cohort study / Martino F. Pengo, Giacomo Rossitto, Valeria Bisogni et al.]. // Blood Pressure. – 2015. – С. 24(2). 124–9.
High prevalence of masked uncontrolled hypertension in people with treated hypertension / José R. Banegas, Luis M. Ruilope, Alejandro de la Sierra et al.]. // European Heart Journal. – 2014. – № 35. – P. 3304–3312.
Julian P. Yaxley. Resistant hypertension: an approach to management in primary care / Julian P. Yaxley, Sam V. Thamba. // J Family Med Prim Care. – 2015. – № 4. – P. 193–199.
Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring / Rios MT, Dominguez-Sardina M, Ayala DE et.al.]. // Chronobiol Int. – 2013. – № 30. – P. 207–20.
Josep Redon. Improving Knowledge of Arterial Resistant Hypertension: What Is Relevant? / Josep Redon. // Rev Esp Cardiol. – 2014. – № 67. – P. 251–3.
Svishhenko E. P. Gipertonicheskaja bolezn'. Vtorichnye gipertenzii. / Svishhenko E. P., Kovalenko V. N. – Kiev: Lybid', 2002. – 504 s. Secondary Hypertension. // SUPPLEMENT TO JAPI. – 2013. – № 61. – P. 24–26.
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboratio / Ryden L, Grant PJ, Anker SD et al.]. // Eur Heart J. – 2013. – № 34. – P. 3035–87.
The Role of Continuous Positive Airway Pressure in Blood Pressure Control for Patients With Obstructive Sleep Apnea and Hypertension: A Meta-Analysis of Randomized Controlled Trials. / Xinyu Hu, Jinqi Fan, Shaojie Chen et al.]. // The Journal of Clinical Hypertension. – 2015. – № 17. – P. 215–222.
Yook Chin Chia. Prevalence and predictors of resistanthypertension in a primary care setting: across-sectional study / Yook Chin Chia, Siew Mooi Ching. // BMC Family Practice. – 2014. – № 15. – P. 131.
Association study of NOS3 gene polymorphisms and hypertension in the Han Chinese population / Linhong Wanga, Chong Shenb, Song Yangc et al.]. // Nitric Oxide. – 2015. – № 51. – P. 1–6.
Lin-Shuang Zhao. Effect of prazosin on diabetic nephropathy patients with positive α1-adrenergic receptor autoantibodies and refractory hypertension / Lin-Shuang Zhao, Chun-Yan Xu. // Experimental and therapeutic medicine. – 2014. – № 27. – P. 177–182.
Molecular Mechanism of Attenuated Inverse Agonism of ARBs for Active-State of AT1 receptor. Research & Reviews / Takanobu Takezako, Hamiyet Unal, Sadashiva S Karnik et al.]. // Journal of Hospital and Clinical Pharmacy. – 2015. – № 1. – P. 17–20.
Do Obese Individuals With Hypertension Have More Difficult-to-Control Blood Pressure and End Organ Damage Than Their Nonobese Counterparts? / Mark David Jesky, Manvir Kaur Hayer, Mark Thomas, Indranil Dasgupta. // The Journal of Clinical Hypertension. – 2015. – № 17. – P. 466–472.
Gifford R. W. Jr. Resistant hypertension / Gifford R. W. Jr. // Hypertension. – 1988. – № 11. – P. 67–70.
ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) / Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al.]. // Journal of Hypertension. – 2013. – № 31. – P. 1281–1187.
Kai Liu. Should More Significance Be Granted to Medication Response to Antihypertensives among patientss With Resistant Hypertension? / Kai Liu, Di Shi, Xiaoping Chen. // Hypertension. – 2014. – № 63. – P. e83.
Resistant hypertension? Assessment of adherence by toxicological urine analysis / Jung O., Gechter JL., Wunder C. et al.]. // J Hypertens. – 2013. – № 31. – P. 766–774.
Heart disease and stroke statistics—2015 update: A report from the American Heart Association / Mozaffarian D, Benjamin EJ, Go AS et al.]. // Circulation. – 2015. – № 131. – P. 29–322.
Teresa Gijón-Conde. Resistant Hypertension: Demography and Clinical Characteristics in 6292 Patients in a Primary Health Care Setting / Teresa Gijón-Conde, Auxiliadora Graciani, José R. Banegas. // Rev Esp Cardiol. – 2014. – № 67. – P. 251–3.
Kaplan N. Kaplan’s Clinical Hypertension / Kaplan N, Victor G.R., 2015. – 471 P. – (11th edition).
Clinical practice guidelines for management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. / Weber MA, Schiffrin EL, While WB et al.]. // J Clin Hypertens. – 2014. – № 16. – P. 14–26.
Yook Chin Chia. Prevalence and predictors of resistanthypertension in a primary care setting: across-sectional study / Yook Chin Chia, Siew Mooi Ching. // BMC Family Practice. – 2014. – № 15. – P. 131.
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) / Muntner P, Davis BR, Cushman WC et al.]. // Hypertension. – 2014. – № 64. – P. 1012–21.
Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study / Haring B, Wu C, Coker LH et al.]. // Am J Hypertens. – 2016. – № 29. – P. 202–16.
Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study / Tsioufis C, Kasiakogias A, Kordalis A et al.]. // J Hypertens. – 2014. – № 32. – P. 415–422.
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. / Kumbhani DJ, Steg PG, Cannon CP et al.]. // Eur Heart J. – 2013. – № 34. – P. 1204–14.
Thomopoulos C. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects among patientss at different levels of cardiovascular risk–overview and meta-analyses of randomized trials. / Thomopoulos C, Parati G, Zanchetti A. // J Hypertens. – 2014. – № 32. – P. 2305–2314.
Schmidt, M. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study / M. Schmidt [et al] // BMJ Open. – 2013. – Vol. 3, № 4. Р. 25–29.
Sima Ghezelbash. Lifestyle modification and hypertension prevention / Sima Ghezelbash, Azam Ghorbani. // ARYA Atherosclerosis Journal. – 2012. – № 8. – P. 202–207.
The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial / [K. M. Diaz, P. Muntner, E. B. Levitan et.al.]. // J Hypertens. – 2014. – № 4. – P. 840–848.
World Health Organization. A global brief on hypertension: silent killer, global public health crisis (World Health Day 2013). Report, 1–39. Geneva, Switzerland: World Health Organization. 2013.
He F. J. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials / F. J. He, J. Li, G. A. Macgregor. // BMJ. – 2013. – № 3. – P. 346.
Perez V. Sodium-to-Potassium Ratio and Blood Pressure, Hypertension, and Related Factors / V. Perez, E. T. Chang. // Adv Nutr. – 2014. – № 6. – P. 712–741.
Relationship between alcohol dependence and new detected hypertension in adult residents of Xuzhou city / [Z. Dong, P. Lou, P. Zhang et al.]. // Zhonghua Xin Xue Guan Bing Za Zhi. – 2015. – № 12. – P. 1083–1087.
Leone A. Vascular pathology from smoking: look at the microcirculation / A. Leone, L. Landini. // Curr Vasc Pharmacol. – 2013. – № 4. – P. 524–530.
Cigarette Smoking and Hypertension / [A. Virdis, C. Giannarelli, M. Fritsch Neves et.al.]. // Current Pharmaceutical Design. – 2015. – №23. – P. 2518–2525.
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). / [N. Naser, A. Dzubur, A. Durak et al.]. // J Clin Biochem Nutr. – 2016. – № 14. – P. 139–144.
The global cardiovascular risk transition: association of four metabolic risk factors with national income, urbanization, and Western diet in 198 and 2008 / [G. Danaei, G. Singh, C. J. Paciorek et al.]. // Circulation. – 2013. – № 127. – P. 1493–1502.
Eckel R. H. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines / Eckel. // Journal of the American College of Cardiology. – 2014. – № 63. – P. 2960.
Lechenie arterial'noj gipertenzii v osobyh klinicheskih situacijah / Pod red. V. N. Kovalenko, E. P. Svishhenko. — KamenecPodol'skij. — ChP Moshaka P.I., 2005. – 504 P.
Albishri J. NSAIDs and hypertension / Albishri. // Anaesth Pain & Intensive Care. – 2013. – № 2. – P. 171–173.
Tofan N. Peculiarities of pharmacotherapy in arterial hypertension and comorbid pathology / N. Tofan, M. Marish, V. Shtanko. // Rev Med Chir Soc Med Nat Iasi. – 2015. – № 4. – P. 1092–1097.
Management of Hypertensive Patients With Multiple Drug Intolerances: A Single-Center Experience of a Novel Treatment Algorithm / [S. Antoniou, M. Saxena, N. Hamedi et al.]. // Journal of Clinical Hypertension. – 2016. – №2. – P. 129–138.
Smith S. M. Epidemiology, prognosis, and treatment of resistant hypertension / Smith. // Pharmacotherapy. – 2013. – № 33. – P. 1071–1086.
Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice / [T. McCormack, C. Arden, A. Begg et al.]. // Br J Cardiol. – 2013. – № 20. – P. 1–16
S. Padwal R. Assessment and management of resistant hypertension / R. S. Padwal, S. Rabkin, N. Khan. // CMAJ. – 2014. – № 186. – P. 689–697.
Effects of combination of perindopril, indapamide, and calcium channel blockers among patientss with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial. / [J. Chalmers, H. Arima, Woodward M et al.]. // Hypertension. – 2014. – № 63. – P. 259–64.
Prevalence of optimal treatment regimens among patientss with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network / [M. Egan, Y. Zhao, J. Li et al.]. // Hypertension. – 2013. – № 62. – P. 691–697.
A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy / L.Xie, F. Frech-Tamas, E. Marrett, O. Baser. // Current Medical Research and Opinion. – 2014. – P. 2415–2422.
Clinical effects of combined olmesartan medoxomil and amlodipine on clinic and ambulatory blood pressure in elderly patients with resistant hypertension / S.Ding, J. Liu, Q. Fu, Y. Zheng. // Arch Gerontol Geriatr. – 2013. – № 57. – P. 423–427.
Impact of the 2014 Expert Panel Recommendations for Management of High Blood Pressure on Contemporary Cardiovascular Practice / [W. B. Borden, T. M. Maddox, F. Tang et al.]. // J Am Coll Cardiol. – 2014. – № 64. – P. 2196–2203.
Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension / [M. A. Weber, G. L. Bakris, M. R. Weir et al.]. // AJM. – P. 501–508.
Evidence-based guidelines for the management of high blood pressure in adults / [P. James, S. Oparil, B. Carter et.al.]. // Report from the panel members appointed to the eighth joint national committee (JNC 8) JAMA. – 2014. – № 5. – P. 507–520.
Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses / [G. Roush, M. Ernst, J. Kostis et al.]. // Journal of Hypertension. – 2016. – № 1. – P. 11–19.
Messerli F. H. Treatment-resistant hypertension: another Cinderella story / F. H. Messerli, S. Bangalore. // Eur Heart J. – 2013. – № 34. – P. 1175–1177.
Yaxley J. P. Resistant hypertension: an approach to management in primary care / J. P. Yaxley, S. V.Thambar. // J Family Med Prim Care. – 2015. – № 2. – P. 193–199.
Kumar N. Management of patients with resistant hypertension: current treatment options / N. Kumar, D. A. Calhoun, T. Dudenbostel. // Integr Blood Press Control. – 2013. – № 6. – P. 139–151.
Hydrochlorothiazide vs. Chlorthalidone as the Optimal Diuretic for the Management of Hypertension / K.Tziomalos, V. G. Athyros, D. P. Mikhailidis, A. Karagiannis. // Current Pharmaceutical Design. – 2013. – № 21. – P. 3766–3772.
Parallel-Group 8-Week Study on Chlorthalidone Effects in Hypertensives With Low Kidney Function / [M. Cirillo, F. Marcarelli, A. A. Mele et al.]. // Hypertension. – 2014. – № 63. – P. 692–697.
Evidence-based diuretics: focus on chlorthalidone and indapamide / J. J.DiNicolantonio, J. Bhutani, C. J. Lavie, J. H. O'Keefe. // Future Cardiology. – 2015. – № 2. – P. 203–217.
Weber M. A. Exploring Issues in Difficult-to-Treat Hypertension / Michael Weber. // The Journal of Clinical Hypertension. – 2013. – № 12. – P. 859–864.
Weber F. Treatment Resistant Hypertension—Investigation and Conservative Management / F. Weber, M. Anlauf. // Dtsch Arztebl Int. – 2014. – № 25. – P. 425–431.
Wolley M. J. Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison. / M. J. Wolley, M. Stowasser. // Curr Hypertens Rep. – 2016. – № 5. – P. 36.
Effect of Spironolactone in Resistant Arterial Hypertension. A Randomized, Double-Blind, Placebo-Controlled Trial (ASPIRANT-EXT). / [J. Václavík, R. Sedlák, J. Jarkovský et al.]. // Medicine (Baltimore). – 2014. – № 27. – P. 162.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial / [B. Williams, T. M. MacDonald, D. J. Webb et al.]. // Lancet. – 2015. – № 386. – P. 2059–2068.
Sternlicht H. Spironolactone for resistant hypertension—hard to resist? / H. Sternlicht, G. L. Bakris. // The Lancet. – 2015. – № 386. – P. 2032–2034.
Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy? / [U. Verdalles, S. G. De Vinuesa, M. Goicoechea et al.]. // Nephrology (Carlton). – 2015. – № 20. – P. 567–571.
The ASCOT Trial-are beta-blockers still useful as antihypertensive medication? / M.Moser, T. D. Giles, T. G. Pickering, R. G. Victor. // J Clin Hypertens (Greenwich). – 2006. – № 10. – P. 723–8.
Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology / [T. Denolle, B. Chamontin, G. Doll et al.]. // Presse Med. – 2014. – № 12. – P. 1325–331.
McComb M. N. Direct Vasodilators and Sympatholytic Agents. / M. N. McComb, J. Y. Chao. // J Cardiovasc Pharmacol Ther. – 2016. – № 1. – P. 3–19.
Sica D. A. Minoxidil: an underused vasodilator for resistant or severe hypertension / Sica. // J Clin Hypertens (Greenwich). – 2004. – № 5. – P. 283–287.
Gorostidi M. Combination Therapy in Hypertension / M. Gorostidi, A. de la Sierra. // Advances in Therapy. – 2013. – № 4. – P. 320–336.
Oparil S. New Approaches in the Treatment of Hypertension / S. Oparil, R. E. Schmieder. // Circulation Research. – 2015. – № 116. – P. 1074–1095.
Lohmeier T. E. The Baroreflex as a Long-Term Controller of Arterial Pressure / T. E. Lohmeier, R. Iliescu. // Physiology (Bethesda). – 2015. – № 2. – P. 148–158.
Victor G. R. Carotid baroreflex activation therapy for resistant hypertension / Ronald Victor. // Nature Reviews Cardiology. – 2015. – № 12. – P. 451–463.
Zhang J. Carotid Baroreceptor Stimulation: A Potential Solution for Resistant Hypertension / J. Zhang, S. Zhou, G. Xu. // Interv Neurol. – 2014. – № 3. – P. 118–122.
Effectiveness of Renal Denervation Therapy for Resistant Hypertension. A Systematic Review and Meta-Analysis / [M. I. Davis, K. B. Filion, D. Zhang et al.]. // J Am Coll Cardiol. – 2013. – № 3. – P. 231–241.
SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension / [D. L. Bhatt, D. E. Kandzari, W. W. O'Neill et al.]. // N Engl J Med. – 2014. – № 370. – P. 1393–1401.
Barley J. Microvascular Decompression Surgery for Refractory Hypertension of Neurogenic Causes / J. Barley, C. Ellis. // The Journal of Clinical Hypertension. – 2013. – № 3. – P. 217.
Sindou M. Hypertension of neurogenic origin: effect of microvascular decompression of the CN IX-X root entry/exit zone and ventrolateral medulla on blood pressure in a prospective series of 48 patients with hemifacial spasm associated with essential hypertension / M. Sindou, M. Mahmoudi, A. Brînzeu. // J Neurosurg. – 2015. – № 6. – P. 1405–1413.
Arteriovenous anastomosis: is this the way to control hypertension? / [A. E. Burchell, M. D. Lobo, N. Sulke et.al.]. // Hypertension. – 2014. – №64. – P. 6–12.
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial / [M. D. Lobo, P. A. Sobotka, A. Stanton et al.]. // Lancet. – 2015. – № 9978. – P. 1634–1641.
McCraty R. Heart Rate Variability: New Perspectives on Physiological Mechanisms, Assessment of Self-regulatory Capacity, and Health risk / R. McCraty, F. Shaffer. // Glob Adv Health Med. – 2015. – № 1. – P. 46–61.
An investigation on biofeedback analysis and psychosomatic applications / S.Saha, D. Dey, I. Bhattacharyya, A. Das. // Recent Developments in Control, Automation and Power Engineering (RDCAPE), 2015 International Conference. – 2015. – P. 38–43.
Peripheral visual performance enhancement by neurofeedback training / [W. Nan, F. Wan, C. I. Lou et al.]. // Appl Psychophysiol Biofeedback. – 2013. – № 4. – P. 285–291.
A smartphone based cardiac coherence biofeedback system / J.De Jonckheere, I. Ibarissene, M. Ibarissene, R. Logier. // Conf Proc IEEE Eng Med Biol Soc. – 2014. – P. 4791–4794.
Fiziologija cheloveka/ v 3-h tomah. pod red. Shmidt R., Tevs G., Ul'mer H.F. (per. s angl. pod red. ak. P.G. Kostjuka). T. – 1. – M: Mir, 2005. – 323.
Cohen R. A. Neural Mechanisms of Attention / Ronald Cohen. // The Neuropsychology of Attention. – 2014. – P. 211–264.
Biofeedback-based training for stress management in daily hassles: an intervention study / [Y. Kotozaki, H. Takeuchi, A. Sekiguchi et al.]. // Brain Behav. – 2014. – № 4. – P. 566–579.
Durand V. M. Abnormal psychology: an integrative aproach / V. M. Durand, D. Barlow. – Stamford, CT: Cengage Learning, 2015. – 784 с.
Hodges G. J. Effect of skin temperature on cutaneous vasodilator response to the β-adrenergic agonist isoproterenol / G. J. Hodges, D. L. Kellogg, J. M. Johnson. // Journal of Applied Physiology. – 2015. – № 7. – P. 898–903.
Freedman R. R. mechanisms of temperature biofeedback / Robert Freedman. // Biofeedback and Self-regulation. – 1991. – № 2. – P. 95–115.
Schwartz M. S. Biofeedback, Fourth Edition: A Practitioner's Guide / M. S. Schwartz, F. Andrasik., 2016. – (4th edition).
Neuromechanical Responses After Biofeedback Training in Participants With Chronic Low Back Pain: An Experimental Cohort Study / [I. Pagé, A. Marchand, F. Nougarou et al.]. // Journal of Manipulative and Physiological Therapeutics. – 2015. – № 7. – P. 449–457.
The Interplay of Pain-Related Self-Efficacy and Fear on Functional Outcomes Among Youth With Headache / [E. Carpino, S. Segal, D. Logan et al.]. // The Journal of Pain. – 2014. – № 5. – P. 527–534.
A randomized-controlled trial of heart rate variability biofeedback for psychotic symptoms. / A.Clamor, J. Clamor, J. F. Thayer, T. M. Lincoln. // Behav Res Ther. – 2016. – № 87. – P. 207–215.
Metrological evaluation of skin conductance measurements. / J.Ogorevc, G. Geršak, D. Novak, J. Drnovšek. // Measurement. – 2013. – № 9. – P. 2993–3001.
Critchley H. Electrodermal Activity (EDA). / H. Critchley, Y. Nagai. // Encyclopedia of Behavioral Medicine. – 2013. – P. 666–669.
Towards a Mobile Galvanic Skin Response Measurement System for Mentally Disordered Patients. / [F. Gravenhorst, A. Muaremi, G. Tröster et al.]. // Proceedings of the 8th International Conference on Body Area Networks. – 2013. – P. 432–435.
Self-control of epileptic seizures by nonpharmacological strategies / [I. Kotwas, A. McGonigal, A. Trebuchon et al.]. // Epilepsy & Behavior. – 2016. – № 55. – P. 157–164.
Biofeedback Treatment for Tourette Syndrome: A Preliminary Randomized Controlled Trial / [Y. Nagai, A. E. Cavanna, H. D. Critchley et al.]. // Cognitive & Behavioral Neurology. – 2014. – № 1. – P. 17–24.
Bembalgi V. Comparative study on the efficacy of electromyography and galvanic skin resistance biofeedback in tension type headache: a single blinded randomized controlled trial. / V. Bembalgi, K. R. Naik. // International Journal on Disability and Human Development. – 2013. – № 3. – P. 353–361.
Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice / [J. Micoulaud-Franchia, A. McGonigal, R. Lopez et al.]. // Neurophysiologie Clinique/Clinical Neurophysiology. – 2015. – № 6. – P. 423–433.
D. Corydon Hammond. Book Review: Handbook of Quantitative Electroencephalography and EEG Biofeedback: Scientific Foundations and Practical Applications / D. Corydon Hammond. // Clin EEG Neurosci. – 2014. – № 45. – P. 59–60.
Sacchet M. D. Neurofeedback training for major depressive disorder: recent developments and future directions. / M. D. Sacchet, I. H. Gotlib. // Expert Rev Neurother. – 2016. – № 9. – P. 1003–1005.
Tanga V. Psychobehavioral therapy for epilepsy / V. Tanga, R. Michaelis, P. Kwan. // Epilepsy & Behavior. – 2014. – № 32. – P. 147–155.
Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. / [M. Rausa, D. Palomba, S. Cevoli et al.]. // J Headache Pain. – 2016. – № 1. – P. 87.
Clinical and neurophysiological data of neurofeedback therapy in children with ADHD / A. Kubik, P. Kubik, M. Stanios, B. Kraj. // Przegl Lek. – 2016. – № 3. – P. 148–151.
Ginsberg G. P. Editorial: Dysregulation of Autonomic Cardiac Control by Traumatic Stress and Anxiety. / Ginsberg. // Front Psychol. – 2016. – № 7. – P. 945.
Sonic respiration: controlling respiration rate through auditory biofeedback / [J. Harris, S. Vance, O. Fernandes et al.]. // CHI'14 Extended Abstracts on Human Factors in Computing Systems. – 2014. – P. 2383–2388.
Psychologically based therapies to improve lung functioning in students with asthma / [C. Maykela, M. Brayb, N. Gelbarc et. al.]. // International Journal of School & Educational Psychology. – 2016. – №2. – P. 79–85.
Kılıç Z. Use of complementary and alternative therapies among sleep problems in individuals with chronic diseases / Z. Kılıç, A. Şentürk, S. Göriş. // Spatula DD. – 2015. – № 5. – P. 69–77.
Cuyler R. N. Effects of therapeutic relationship, expectancy, and credibility in breathing therapies for anxiety / Robert Cuyler. // Bulletin of the Menninger Clinic. – 2015. – № 4. – P. 356–361.
Poppy L. A. Schoenberg. Biofeedback for Psychiatric Disorders: A Systematic Review. / Poppy L. A. Schoenberg, Anthony S. David. // Applied Psychophysiology and Biofeedback. – 2014. – № 2. – P. 109–135.
Go-with-the-Flow: Tracking, Analysis and Sonification of Movement and Breathing to Build Confidence in Activity Despite Chronic Pain / [A. Singh, S. Piana, D. Pollarolo et al.]. // Human–Computer Interaction. – 2016. – № 3. – P. 335.
Wearable Biomedical Measurement Systems for Assessment of Mental Stress of Combatants in Real Time / [F. Seoane, I. Mohino-Herranz, J. Ferreira et al.]. // Sensors. – 2014. – № 14. – P. 7120–7141.
Identification of isometric contractions based on High Density EMG maps. / М.Rojas-Martínez, M. A. Mañanas, J. F. Alonso, R. Merletti. // Journal of Electromyography and Kinesiology. – 2013. – № 1. – P. 33–42.
Surface EMG Biofeedback, in Surface Electromyography : Physiology, Engineering, and Applications / А.Gallina, М. Gazzoni, D. Falla, R. Merletti. – Hoboken, New Jersey: John Wiley & Sons, Inc, 2016. – 570 с.
Kang D. Y. Deep cervical flexor training with a pressure biofeedback unit is an effective method for maintaining neck mobility and muscular endurance in college students with forward head posture / Dong Yeon Kang. // J Phys Ther Sci. – 2015. – № 27. – P. 3207–3210.
Jahanbazi А. Effects of EMG Biofeedback on Pain and Quality of Life in Cervical Dystonia / А. Jahanbazi, А. Chitsaz, К. Asgari. // J Neurol Disord. – 2013. – № 2. – P. 144.
Giggins О. М. Biofeedback in rehabilitation / О. М. Giggins, U. M. Persson, B. Caulfield. // J Neuroeng Rehabil. – 2013. – № 10. – P. 60.
Lehrer P. M. Heart rate variability biofeedback: how and why does it work? / P. M. Lehrer, R. Gevirtz. // Front Psychol. – 2014. – № 5. – P. 756.
Kimmel H. D. Instrumental conditioning of autonomically mediated responses in human beings / Kimmel. // Am Psychol. – 1974. – P. 325–335.
Cardiovascular dysfunctions and sympathovagal imbalance in hypertension and prehypertension: physiological perspectives / [G. K. Pal, P. Pal, N. Nanda et.al.]. // Future Cardiology. – 2013. – № 9. – P. 53.
Shaffer F. Heart rate variability anatomy and physiology / F. Shaffer, J. Venner. // Biofeedback. – 2013. – № 41. – P. 13–25.
Gomes J. S. Cardiovascular Biofeedback and its Applications: Review of Literature / J. S. Gomes, M. F. Coghi. // Av. Psicol. Latinoam. – 2013. – № 2. – P. 1794–4724.
Gevirtz R. The Promise of Heart Rate Variability Biofeedback: Evidence-Based Applications / Richard Gevirtz. // Biofeedback. – 2013. – № 3. – P. 110–120.
Shaffer F. A healthy heart is not a metronome: an integrative review of the heart's anatomy and heart rate variability / F. Shaffer, R. McCraty, C. L. Zerr. // Front Psychol. – 2014. – № 5. – P. 1040.
Utilizing heartbeat evoked potentials to identify cardiac regulation of vagal afferents during emotion and resonant breathing / S.MacKinnon, R. Gevirtz, R. McCraty, M. Brown. // Appl Psychophysiol Biofeedback. – 2013. – № 38. – P. 241–255.
Research and development of portable hypertension therapeutic apparatus based on biofeedback mechanism / [R. Huang, H. He, X. Pi et al.]. // Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. – 2014. – № 31. – P. 586–589.
Lehrer P. М. How does heart rate variability biofeedback work? Resonance, the baroreflex, and other mechanisms. / М. Lehrer. // Biofeedback. – 2013. – № 41. – P. 26–31.
Sympathetic Nerve Fibers in Human Cervical and Thoracic Vagus Nerves / [A. Seki, H. R. Green, T. D. Lee et al.]. // Heart Rhythm. – 2014. – № 11. – P. 1411–1417.
Rhoades R. A. Medical Physiology: Principles for Clinical Medicine. 4th ed. / R. A. Rhoades, D. R. Bell. – Baltimore, MD: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2013. – P. 311–325.
Alternative medicine in atrial fibrillation treatment—Yoga, acupuncture, biofeedback and more / [А. Kanmanthareddy, М. Reddy, G. Ponnaganti et al.]. // J Thorac Dis. – 2015. – № 7. – P. 185–192.
McKee M. Biofeedback in the treatment of heart failure / M. McKee, C. Moravec. // Cleve Clin J Med. – 2010. – № 77. – P. 56–59.
Randomized controlled trial of heart rate variability biofeedback in cardiac autonomic and hostility among patients with coronary artery disease / [I. Lin, S. Fan, H. Lua et al.]. // Behaviour Research and Therapy. – 2015. – № 70. – P. 38–46.
The role of biofeedback in the rehabilitation of veno-occlusive erectile dysfunction. / [M. R. Al-Helow, H. Abdul-Hady, M. M. Fathalla et al.]. // Egyptian rheumatology and rehabilitation. – 2014. – №41. – P. 179–186.
Clinical effectiveness of stress-reduction techniques among patientss with hypertension: systematic review and meta-analysis. / [E. Nagele, K. Jeitler, K. Horvath et al.]. // Journal of Hypertension. – 2014. – № 32. – P. 1936–1944.
A brief review and clinical application of heart rate variability. Biofeedback in sports, exercise, and rehabilitation medicine / [G. E. Prinsloo, L. Rauch, W. E. Derman et al.]. // The Physician and Sportsmedicine. – 2014. – № 42. – P. 88–99.
Newman J. B. Heart disease: from psychosocial to pathophysiological to treatment with biofeedback – An overview / Jan Newman. // Biofeedback. – 2013. – № 41. – P. 39–42.
Exercise-based cardiac rehabilitation among patientss with chronic heart failure: a Dutch practice guideline. / [R. J. Achttien, J. B. Staal, H. M. Kemps et al.]. // Netherlands Heart Journal. – 2015. – № 23. – P. 6–17.
Siah K. T. Chronic constipation and constipation predominant. IBS: separate and distinct. Disorders or a spectrum of disease? / K. T. Siah, R. K. Wong, W. E. Whitehead. // Gastroenterology & Hepatology. – 2016. – № 12. – P. 171–178.
Feasibility of a capnometry device for respiratory biofeedback among patientss undergoing coronary artery bypass graft surgery. / O.Grishin, V. Gultyaeva, M. Zinchenko, D. Uryumtsev. // Biomedical Engineering and Computational Technologies (SIBIRCON), 2015 International Conference on 28–30 Oct. 2015. – P. 22–26.
Protocol for heart rate variability biofeedback training / [P. Lehrer, B. Vaschillo, T. Zucker et.al.]. // Biofeedback. – 2013. – № 41. – P. 98–109.
Hasan W. Autonomic cardiac innervation: Development and adult plasticity. / Hasan. // Organogenesis. – 2013. – № 9. – P. 176–193.
Effect of feedback signal on blood pressure self-regulation capability in individuals with prehypertension or stage I hypertension: a randomized controlled study / [M. Wang, N. Chang, M. Hsieh et al.]. // Journal of Cardiovascular Nursing. – 2016. – №31. – P. 166–172.
Comparative study of Heart Rate Variability in normotensive offsprings of hypertensive parents / [S. Chinagudi, A. Herur, S. Patil et al.]. // Biomedical Research. – 2013. – № 24– P. 123–126.
Effects of heart rate variability biofeedback on cardiovascular responses and autonomic sympathovagal modulation following stressor tasks in prehypertensives / S. Chen, P. Sun, S. Wang et al.]. // Journal of Human Hypertension. – 2016. – № 30. – P. 105–111.
The success of heart rate variability biofeedback parameters in persons with different levels of blood pressure. / Poskotinova L.V., Demin D.B., Krivonogova E.V. et al.]. // Vestn Ross Akad Med Nauk. – 2013. – № 7. – P. 20–23.
Cernes R. RESPeRATE: the role of paced breathing in hypertension treatment. / Cernes R., Zimlichman R. // J Am Soc Hypertens. – 2015. – № 9. – P. 38–47.
Effect of slow abdominal breathing combined with biofeedback on blood pressure and heart rate variability in prehypertension. / Shu-Zhen Wang, Sha Li, Xiao-Yang Xu et.al.]. // The Journal of Alternative and Complementary Medicine. – 2010. – № 16. – P. 1039–1045.
Device-guided breathing exercises for the treatment of hypertension: An overview. / Kornelis JJ van Hateren, Gijs WD Landman, Susan JJ Logtenberg et al.]. // World J Cardiol. – 2014. – № 6. – P. 277–282.
Shaffer F. Biofeedback. Textbook of complementary and alternative medicine / Shaffer F., Bieber E. J., Bauer. B. A. – Abingdon, Oxfordshire: UK: Informa Healthcare, 2006. – (2).
Effectiveness of biofeedback in the closed loop of heart rate variability and paced breathing in the patients with somatoform autonomic dysfunction. / Akhimienmhona P. D, Oreofe A. B, Belal S. A. S, Kulyk V. L. // Vestnik Har'kovskogo nacional'nogo universiteta imeni V.N. Karazina. Serija «Medicina». – 2014. – № 28. – S. 23–27
Belal S. A. S. The influence of biofeedback sessions in closed loop of heart rate variability and paced breathing on systolic blood pressure control during standard drug therapy in patients with arterial hypertension. / Belal S. A. S, Vodyanitska N. A, Yabluchansky M. I. // Vestnik Khar'kovskogo nacional'nogo universiteta imeni V. N. Karazina. Serija «Medicina». – 2015. – № 29. – S. 11–21.
Vpliv seansiv biologichnogo zvorotn'ogo zv'jazku v konturi metronomizovannogo dihannja ta paremetriv variabel'nosti sercevogo ritmu na jakist' zhittja pacientiv iz arterial'noju gipertenzieju. / Nazarenko E. O, Radchenko A. O., Belal S. A. S, Yabluchansky M. I. // Ukrains'kij naukovo-medichnij molodizhnij zhurnal. – 2015. – № 3. – P. 103–106.
Implementation of Biofeedback in a Closed Loop of Heart Rate Variability and Paced Breathing among patientss with Arterial Hypertension / O. L. Kulik, O. J. Schmidt, S. A. S. Belal, I. A. Rank. // Journal of V. N. Karazin KhNU, series «Medicine». – 2014. – № 1108. – P. 10–15.
Ispol'zovanie biologicheskoj obratnoj svjazi v zamknutom konture variabel'nosti serdechnogo ritma i metronomizirovannogo dyhanija u pacientov s arterial'noj gipertenziej / A. L. Kulik, E. Ju. Shmidt // Materіali naukovo-praktichnoї konferencії za uchastju mіzhnarodnih specіalіstіv «Aktual'nі pitannja suchasnoї psihіatrії, narkologії ta nevrologії», Kharkіv, 14–15 kvіtnja 2014 r. / Za zagal'noju redakciyeyu prof. V. І.Ponomar'ova. – Kharkіv.
Copyright (c) 2017 O. S. Tymoshenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
